| Title |
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, March 2009
|
| DOI | 10.1007/s00262-009-0681-z |
| Pubmed ID | |
| Authors |
Cedrik Michael Britten, Sylvia Janetzki, Leah Ben-Porat, Timothy M. Clay, Michael Kalos, Holden Maecker, Kunle Odunsi, Michael Pride, Lloyd Old, Axel Hoos, Pedro Romero, for the HLA-peptide Multimer Proficiency Panel of the CVC-CRI Immune Assay Working Group |
| Abstract |
The Cancer Vaccine Consortium of the Cancer Research Institute (CVC-CRI) conducted a multicenter HLA-peptide multimer proficiency panel (MPP) with a group of 27 laboratories to assess the performance of the assay. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 2% |
| Czechia | 1 | 2% |
| Belgium | 1 | 2% |
| Unknown | 54 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 21% |
| Other | 9 | 16% |
| Student > Ph. D. Student | 6 | 11% |
| Professor > Associate Professor | 6 | 11% |
| Student > Master | 6 | 11% |
| Other | 12 | 21% |
| Unknown | 6 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 25 | 44% |
| Immunology and Microbiology | 10 | 18% |
| Agricultural and Biological Sciences | 8 | 14% |
| Mathematics | 2 | 4% |
| Biochemistry, Genetics and Molecular Biology | 2 | 4% |
| Other | 1 | 2% |
| Unknown | 9 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 August 2011.
All research outputs
#15,233,109
of 22,649,029 outputs
Outputs from Cancer Immunology, Immunotherapy
#2,151
of 2,882 outputs
Outputs of similar age
#78,571
of 93,048 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#31
of 32 outputs
Altmetric has tracked 22,649,029 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,882 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 93,048 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.